Fundamental Data for AMAG

AMAG PHARM(NSDQ:AMAG)

Advanced Magnetics, Inc. is a developer of superparamagnetic iron oxide nanoparticles used in pharmaceutical products. As a leader in our field, we are dedicated to the development and commercialization of our proprietary nanoparticle technology for use in therapeutic iron compounds to treat anemia, as well as novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

# Employees: 259

Address: 125 CambridgePark Drive,Cambridge,MA,USA

Phone: 617-498-3300

Fax: 617-499-3361

Website: www.amagpharma.com

Email: contactus@amagpharma.com

Sector: Medical

Industry: MED INSTRUMENTS

Executive Officers

Ron Zwanziger (Dir.)

Brian J.G. Pereira (Presi.; C.E.O.; Dir.)

David A. Arkowitz (C.F.O.; Chief Buss. Off.)

Michael Narachi (Dir.)

Michael D. Loberg (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/19/2010

Mean EPS (Next Qtr): ($1.17)

Mean EPS (Year): ($5.57)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 9

Shares Performance

Period	AMAG	Compare to S&P
YTD	10.88 %	-8.23 %
4 Weeks	10.42 %	9.22 %
12 Weeks	-3.92 %	-9.41 %

Shares Information

Analyst Coverage: Y

Avg Volume: 696703

Shares Outstanding: 17M

Market Cap: $0.68B

52 Week High: $55.91

52 Week Low: $24.24

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 9/26/1991 AMAG split by factor of 1.500

Earnings Performance

EPS Growth in Last Quarter: 16.77 %

EPS Growth in Last Year: 7.19 %

Sales Growth in Last Quarter: 5,392.73 %

Sales Growth in Last Quarter: 1,061.92 %

Financials

Qtr Book Value: $4.36

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 147.550